PLX stock

An Analysis of Protalix BioTherapeutics Inc (PLX)’s Potential Price Growth

Anna Perez

Protalix BioTherapeutics Inc’s recent filing unveils that its Director Schwartz Aharon acquired Company’s shares for reported $0.21 million on Jun ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.